Investment Analysts’ updated eps estimates for Monday, February 3rd:
AbbVie (NYSE:ABBV) had its outperform rating reiterated by analysts at Raymond James. Raymond James currently has a $220.00 price target on the stock, up from their previous price target of $218.00.
Ameris Bancorp (NASDAQ:ABCB) had its outperform rating reaffirmed by analysts at Raymond James. The firm currently has a $71.00 price target on the stock, up from their previous price target of $67.00.
Ameriprise Financial (NYSE:AMP) had its outperform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $625.00 price target on the stock.
AnaptysBio (NASDAQ:ANAB) had its outperform rating reiterated by analysts at Wedbush. The firm currently has a $40.00 target price on the stock.
Aptiv (NYSE:APTV) had its market perform rating reissued by analysts at Raymond James.
AXIS Capital (NYSE:AXS) had its market perform rating reiterated by analysts at JMP Securities.
Booz Allen Hamilton (NYSE:BAH) was upgraded by analysts at Raymond James from a market perform rating to an outperform rating. The firm currently has $150.00 target price on the stock.
Beam Therapeutics (NASDAQ:BEAM) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $80.00 target price on the stock.
Brookfield Renewable Partners (NYSE:BEP) (TSE:BEP) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $31.00 price target on the stock.
Bread Financial (NYSE:BFH) had its market perform rating reiterated by analysts at JMP Securities.
Braze (NASDAQ:BRZE) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $50.00 target price on the stock.
Caterpillar (NYSE:CAT) was upgraded by analysts at UBS Group AG from a sell rating to a neutral rating. They currently have $385.00 price target on the stock, up from their previous price target of $355.00.
Church & Dwight (NYSE:CHD) had its sector perform rating reiterated by analysts at Royal Bank of Canada. They currently have a $105.00 target price on the stock.
The Cigna Group (NYSE:CI) had its overweight rating reaffirmed by analysts at Piper Sandler. They currently have a $348.00 price target on the stock, down from their previous price target of $394.00.
Colgate-Palmolive (NYSE:CL) had its outperform rating reiterated by analysts at Raymond James. The firm currently has a $105.00 price target on the stock, down from their previous price target of $110.00.
Costco Wholesale (NASDAQ:COST) had its outperform rating reissued by analysts at Telsey Advisory Group. They currently have a $1,100.00 price target on the stock.
CrowdStrike (NASDAQ:CRWD) had its neutral rating reiterated by analysts at Robert W. Baird. Robert W. Baird currently has a $430.00 target price on the stock, up from their previous target price of $390.00.
Cantaloupe (NASDAQ:CTLP) had its outperform rating reissued by analysts at Barrington Research. Barrington Research currently has a $12.00 price target on the stock.
Cavco Industries (NASDAQ:CVCO) had its neutral rating reissued by analysts at Wedbush. The firm currently has a $550.00 target price on the stock, up from their previous target price of $480.00.
Chevron (NYSE:CVX) had its outperform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $175.00 target price on the stock.
Quest Diagnostics (NYSE:DGX) had its neutral rating reaffirmed by analysts at Piper Sandler. Piper Sandler currently has a $180.00 price target on the stock, up from their previous price target of $165.00.
Danaher (NYSE:DHR) had its market perform rating reissued by analysts at Raymond James.
DexCom (NASDAQ:DXCM) was upgraded by analysts at Redburn Atlantic from a neutral rating to a buy rating. Redburn Atlantic currently has $115.00 target price on the stock, up from their previous target price of $85.00.
Evaxion Biotech A/S (NASDAQ:EVAX) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $14.00 price target on the stock.
Financial Institutions (NASDAQ:FISI) was upgraded by analysts at Keefe, Bruyette & Woods from a market perform rating to an outperform rating. The firm currently has $34.00 price target on the stock, up from their previous price target of $29.00.
Firstsun Capital Bancorp (NASDAQ:FSUN) had its outperform rating reiterated by analysts at Keefe, Bruyette & Woods. The firm currently has a $47.00 price target on the stock, up from their previous price target of $46.00.
Fortinet (NASDAQ:FTNT) had its neutral rating reissued by analysts at Robert W. Baird. The firm currently has a $112.00 target price on the stock, up from their previous target price of $105.00.
Gilead Sciences (NASDAQ:GILD) had its sector perform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $84.00 target price on the stock.
Gentex (NASDAQ:GNTX) had its buy rating reaffirmed by analysts at B. Riley. They currently have a $32.50 target price on the stock, down from their previous target price of $37.00.
The Hartford Financial Services Group (NYSE:HIG) had its sector perform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $125.00 target price on the stock.
Hershey (NYSE:HSY) had its sector perform rating reaffirmed by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $178.00 price target on the stock.
Invivyd (NASDAQ:IVVD) had its buy rating reiterated by analysts at D. Boral Capital. D. Boral Capital currently has a $9.00 target price on the stock.
KeyCorp (NYSE:KEY) had its neutral rating reissued by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $18.50 price target on the stock.
Kenvue (NYSE:KVUE) had its sector perform rating reissued by analysts at Royal Bank of Canada. They currently have a $24.00 price target on the stock.
Lennox International (NYSE:LII) had its underweight rating reissued by analysts at Wells Fargo & Company. Wells Fargo & Company currently has a $580.00 target price on the stock, down from their previous target price of $630.00.
Liquidity Services (NASDAQ:LQDT) had its outperform rating reiterated by analysts at Barrington Research. Barrington Research currently has a $40.00 price target on the stock.
NextEra Energy Partners (NYSE:NEP) had its underweight rating reiterated by analysts at Morgan Stanley. Morgan Stanley currently has a $13.00 price target on the stock, down from their previous price target of $22.00.
Cloudflare (NYSE:NET) had its neutral rating reissued by analysts at Robert W. Baird. They currently have a $140.00 target price on the stock, up from their previous target price of $125.00.
Northrop Grumman (NYSE:NOC) was upgraded by analysts at Wolfe Research from an underperform rating to a peer perform rating.
OneMain (NYSE:OMF) had its overweight rating reaffirmed by analysts at Stephens. They currently have a $62.00 target price on the stock.
OneMain (NYSE:OMF) had its market outperform rating reaffirmed by analysts at JMP Securities. They currently have a $65.00 price target on the stock.
Oncolytics Biotech (NASDAQ:ONCY) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $5.00 target price on the stock.
Orrstown Financial Services (NASDAQ:ORRF) had its outperform rating reissued by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $42.00 price target on the stock, down from their previous price target of $46.00.
Proficient Auto Logistics (NASDAQ:PAL) had its outperform rating reissued by analysts at Barrington Research. Barrington Research currently has a $15.00 target price on the stock.
Piper Sandler Companies (NYSE:PIPR) had its market perform rating reaffirmed by analysts at JMP Securities.
Piper Sandler Companies (NYSE:PIPR) had its market perform rating reissued by analysts at JMP Securities.
Prologis (NYSE:PLD) had its market perform rating reiterated by analysts at Raymond James.
Peloton Interactive (NASDAQ:PTON) had its market perform rating reaffirmed by analysts at Telsey Advisory Group. They currently have a $11.00 price target on the stock.
Reynolds Consumer Products (NASDAQ:REYN) had its sector perform rating reissued by analysts at Royal Bank of Canada. They currently have a $32.00 target price on the stock.
Roku (NASDAQ:ROKU) had its market outperform rating reissued by analysts at JMP Securities. They currently have a $95.00 target price on the stock.
Revvity (NYSE:RVTY) had its outperform rating reiterated by analysts at Raymond James. Raymond James currently has a $145.00 target price on the stock, up from their previous target price of $140.00.
Silicom (NASDAQ:SILC) had its hold rating reaffirmed by analysts at Needham & Company LLC.
SJW Group (NYSE:SJW) was upgraded by analysts at Bank of America Co. from a neutral rating to a buy rating. The firm currently has $55.00 target price on the stock, down from their previous target price of $59.00.
Snap-on (NYSE:SNA) had its outperform rating reiterated by analysts at Barrington Research. Barrington Research currently has a $360.00 target price on the stock.
Schneider National (NYSE:SNDR) had its equal weight rating reaffirmed by analysts at Stephens. The firm currently has a $30.00 target price on the stock, down from their previous target price of $32.00.
SS&C Technologies (NASDAQ:SSNC) was upgraded by analysts at Jefferies Financial Group Inc. from a hold rating to a buy rating. Jefferies Financial Group Inc. currently has $94.00 price target on the stock, up from their previous price target of $70.00.
Stratasys (NASDAQ:SSYS) had its overweight rating reissued by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $12.00 target price on the stock.
Stratasys (NASDAQ:SSYS) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $12.00 price target on the stock.
Constellation Brands (NYSE:STZ) had its outperform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $293.00 target price on the stock.
Sunrise Realty Trust (NASDAQ:SUNS) had its outperform rating reaffirmed by analysts at Raymond James. Raymond James currently has a $15.00 target price on the stock, down from their previous target price of $17.50.
Bancorp (NASDAQ:TBBK) had its outperform rating reissued by analysts at Raymond James. Raymond James currently has a $67.00 target price on the stock, up from their previous target price of $60.00.
Thermo Fisher Scientific (NYSE:TMO) had its outperform rating reaffirmed by analysts at Raymond James. Raymond James currently has a $667.00 price target on the stock, up from their previous price target of $650.00.
Tenaya Therapeutics (NASDAQ:TNYA) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $18.00 price target on the stock.
Tempur Sealy International (NYSE:TPX) had its outperform rating reiterated by analysts at Wedbush. They currently have a $80.00 price target on the stock, up from their previous price target of $67.00.
Tower Semiconductor (NASDAQ:TSEM) had its outperform rating reissued by analysts at Wedbush. They currently have a $60.00 price target on the stock.
Unity Software (NYSE:U) had its market perform rating reaffirmed by analysts at JMP Securities.
Universal Health Services (NYSE:UHS) was upgraded by analysts at Cantor Fitzgerald from a neutral rating to an overweight rating.
UMB Financial (NASDAQ:UMBF) had its neutral rating reissued by analysts at Citigroup Inc.. The firm currently has a $127.00 target price on the stock, down from their previous target price of $130.00.
Weyerhaeuser (NYSE:WY) had its outperform rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $36.00 price target on the stock.
United States Steel (NYSE:X) had its equal weight rating reissued by analysts at Morgan Stanley. Morgan Stanley currently has a $39.00 price target on the stock.
Exxon Mobil (NYSE:XOM) had its sector perform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $115.00 price target on the stock.
Zillow Group (NASDAQ:ZG) was upgraded by analysts at KeyCorp from a sector weight rating to an overweight rating. KeyCorp currently has $100.00 target price on the stock.
Receive News & Ratings for AbbVie Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AbbVie Inc and related companies with MarketBeat.com's FREE daily email newsletter.
